Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Bicycle Therapeutics (BCYC) Income from Continuing Operations (2018 - 2026)

Bicycle Therapeutics (BCYC) has disclosed Income from Continuing Operations for 9 consecutive years, with 60825000.0 as the latest value for Q1 2026.

  • For Q1 2026, Income from Continuing Operations changed 0.14% year-over-year to 60825000.0; the TTM value through Mar 2026 reached 225727000.0, down 856.59%, while the annual FY2025 figure was 225656000.0, 2226.02% down from the prior year.
  • Income from Continuing Operations hit 60825000.0 in Q1 2026 for Bicycle Therapeutics, down from 26850000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 127791000.0 in Q4 2024 and bottomed at 78952000.0 in Q2 2025.
  • Average Income from Continuing Operations over 5 years is 33835823.53, with a median of 39797000.0 recorded in 2024.
  • Year-over-year, Income from Continuing Operations soared 341.5% in 2024 and then tumbled 129.1% in 2025.
  • Bicycle Therapeutics' Income from Continuing Operations stood at 32032000.0 in 2022, then plummeted by 65.19% to 52915000.0 in 2023, then skyrocketed by 341.5% to 127791000.0 in 2024, then crashed by 121.01% to 26850000.0 in 2025, then plummeted by 126.54% to 60825000.0 in 2026.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 60825000.0, 26850000.0, and 59100000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.